Home » Sorin Group Acquires Gish Biomedical
Sorin Group Acquires Gish Biomedical
Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced Tuesday that it has acquired Gish Biomedical from Ventizz Capital Partners, a private equity group focused on technology-oriented companies.
Forbes
Forbes
Upcoming Events
-
14May
-
23May
-
30May
-
20Jun
-
21Oct